Tag: Axalimogene Filolisbac
FDA lifts clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial
Advaxis revealed that the US Food and Drug Administration (FDA) has removed a previously imposed clinical hold on its Phase 1/2 trial of Axalimogene Filolisbac ... Read More